SAMDaily.us | PRESOL | A | Perform an interlaboratory reproducibility study and obtain experimental data to identify specific organism/drug combinations that may exhibit biological variability when testing is performed using the CLSI BMD method.

SAMDAILY.US - ISSUE OF AUGUST 11, 2022 SAM #7559
SOLICITATION NOTICE

A -- Perform an interlaboratory reproducibility study and obtain experimental data to identify specific organism/drug combinations that may exhibit biological variability when testing is performed using the CLSI BMD method.

Notice Date: 8/9/2022 7:38:16 AM
Notice Type: Combined Synopsis/Solicitation
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Silver Spring MD 20993 USA
ZIP Code: 20993
Solicitation Number: FDARFP1258398
Response Due: 8/16/2022 11:00:00 AM
Archive Date: 08/31/2022
Point of Contact: Howard S Yablon, Phone: 2404027630
E-Mail Address: howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
Small Business Set-Aside: SBA Total Small Business Set-Aside (FAR 19.5)
Description: Perform an interlaboratory reproducibility study and obtain experimental data to identify specific organism/drug combinations that may exhibit biological variability when testing is performed using the CLSI BMD method. See Attachment for solicitation. See Attachment 1 for Statement of Work. See Attachment 2 for IPP Invoicing Instructions.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/dd4fd54bb0a44310bc528ab941908d23/view)
Place of Performance: Address: Silver Spring, MD 20993, USA; Zip Code: 20993; Country: USA
Record: SN06419131-F 20220811/220809230115 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |